+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A new method to detect lymphocytic choriomeningitis virus-specific antibody in human sera



A new method to detect lymphocytic choriomeningitis virus-specific antibody in human sera



Journal of General Virology 37(1): 85-92



A plaque reduction method for measuring lymphocytic choriomeningitis virus-sensitizing antibody in human serum is described. One volume of virus and one volume of serially diluted human serum were mixed and incubated for 2 h at 37 degrees C. One volume of suitably diluted anti-human immune globulin antiserum was added and incubation continued for 0-5 h. Residual infectivity was then determined by means of a plaque assay employing L cell monolayer cultures and a methyl cellulose containing overlay medium. Of 75 sera from as many persons, 20 were positive with titres ranging from 640 to 10240. All positive sera were from verified cases or from persons who had had occupational contact with the virus. Close correlation of results was found between this method and a neutralization test employing mice, the one exception indicating that the in vitro assay for sensitizing antibody is more sensitive than the mouse assay for neutralizing antibody.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 039087443

Download citation: RISBibTeXText

PMID: 335024

DOI: 10.1099/0022-1317-37-1-85


Related references

An improved method for determining neutralizing antibody against lymphocytic choriomeningitis virus in human sera. Journal of General Virology 41(2): 377-383, 1978

Analysis of neutralizing antibody specificities of different strains of lymphocytic choriomeningitis virus with strain-specific immune sera. Research In Virology. 144(6): 471-478, 1993

Detection of lymphocytic choriomeningitis virus antibody in murine sera by immunofluorescence. Applied Microbiology 18(2): 289-290, 1969

Lymphocytic choriomeningitis virus glycoprotein expressed in vaccinia virus allows h 2 restricted lymphocytic choriomeningitis virus specific cytotoxic t lymphocyte recognition lysis. Federation Proceedings 45(4): 979, 1986

Enzyme-linked immunosorbent assay for detection of antibody to lymphocytic choriomeningitis virus in mouse sera, with recombinant nucleoprotein as antigen. Laboratory Animal Science 45(5): 493-496, 1995

A study of human sera antibodies capable of neutralizing the virus of lymphocytic choriomeningitis. Publ Health Repts 54(22): 938-944, 1939

Specific inactivation of antibody production in lymphocytic choriomeningitis-virus infected mice. Kiserletes Orvostudomany 7(6): 647-653, 1955

Mechanism of recovery from acute virus infection. VIII. Treatment of lymphocytic choriomeningitis virus-infected mice with anti-interferon-gamma monoclonal antibody blocks generation of virus-specific cytotoxic T lymphocytes and virus elimination. European Journal of Immunology 19(7): 1283-1288, 1989

Virus-induced immune complex disease: specific anti-viral antibody and C1q binding material in the circulation during persistent lymphocytic choriomeningitis virus infection. Journal of Immunology 124(2): 831-838, 1980

Factors influencing specific antibody formation in mice persistently infected with lymphocytic choriomeningitis virus. Zentralblatt fuer Veterinaermedizin Reihe B 28(2): 133-145, 1981

Virus specificity of cytotoxic T lymphocytes generated during acute lymphocytic choriomeningitis virus infection: role of the H-2 region in determining cross-reactivity for different lymphocytic choriomeningitis virus strains. Journal of Virology 51(1): 34-41, 1984

The demonstration of substances in human sera which inhibit complement fixation in antigen-antibody systems of lymphogranuloma venereum, psittacosis, mumps, Q fever, and lymphocytic choriomeningitis. Journal of Bacteriology 71(2): 217-222, 1956

Detection of the antibody to lymphocytic choriomeningitis virus in sera of laboratory rodents infected with viruses of laboratory and newly isolated strains by ELISA using purified recombinant nucleoprotein. Experimental Animals 57(4): 357-365, 2008

Fatal central nervous system disease in lymphocytic choriomeningitis virus carrier mice given lymphocytic choriomeningitis virus immune donor spleen cells. Federation Proceedings 30(2): 353, 1971

Impaired generation of anti-viral cytotoxicity against lymphocytic choriomeningitis and vaccinia virus in mice treated with CD4-specific monoclonal antibody. Scandinavian Journal of Immunology 30(6): 679-686, 1989